Early Identification of Interleukin-16 (Lymphocyte Chemoattractant Factor) and Macrophage Inflammatory Protein 1 α (MIP1 α) in Bronchoalveolar Lavage Fluid of Antigen-Challenged Asthmatics
William W. Cruikshank(Boston University), Stephen T. Holgate(University of Southampton), Robert E. Tarpy(Boston University), Hardy Kornfeld(University of Massachusetts Chan Medical School), Luis M. Terán(Boston University), M. P. Carroll(Boston University), A Long(Boston University)
American Journal of Respiratory Cell and Molecular Biology
December 1, 1995
Cited by 147
Related Papers
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma
|Journal of Allergy and Clinical Immunology|2010|746
Treatment strategies for allergy and asthma
|Nature reviews. Immunology|2008|687
The Relationship Between Upper Respiratory Infections and Hospital Admissions for Asthma: A Time-Trend Analysis
|American Journal of Respiratory and Critical Care Medicine|1996|571
Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma
|Clinical & Experimental Allergy|2004|520